Positioning oral selective estrogen receptor degraders in patients with metastatic breast cancer.
Saved in:
| Title: | Positioning oral selective estrogen receptor degraders in patients with metastatic breast cancer. |
|---|---|
| Authors: | Valenza C; European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy., Curigliano G; European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy. Electronic address: giuseppe.curigliano@ieo.it. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Oct 01; Vol. 228, pp. 115739. Date of Electronic Publication: 2025 Aug 21. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
